Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neisseria gonorrhoeae | 11 | 2021 | 35 | 3.720 |
Why?
|
| Penicillin-Binding Proteins | 11 | 2019 | 15 | 3.310 |
Why?
|
| Bacterial Proteins | 16 | 2021 | 245 | 3.280 |
Why?
|
| Glucose-6-Phosphate Isomerase | 9 | 2004 | 10 | 1.830 |
Why?
|
| Crystallography, X-Ray | 32 | 2018 | 190 | 1.680 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 3 | 2020 | 5 | 1.520 |
Why?
|
| Escherichia coli | 7 | 2010 | 368 | 1.230 |
Why?
|
| Models, Molecular | 28 | 2021 | 546 | 1.150 |
Why?
|
| Penicillins | 4 | 2012 | 32 | 1.140 |
Why?
|
| Binding Sites | 20 | 2019 | 631 | 1.130 |
Why?
|
| Cephalosporin Resistance | 3 | 2020 | 5 | 1.030 |
Why?
|
| Gonorrhea | 3 | 2021 | 50 | 0.960 |
Why?
|
| Amino Acid Sequence | 25 | 2010 | 1083 | 0.900 |
Why?
|
| Molecular Sequence Data | 24 | 2010 | 1447 | 0.870 |
Why?
|
| Pyrobaculum | 4 | 2013 | 4 | 0.850 |
Why?
|
| Protein Conformation | 15 | 2018 | 362 | 0.740 |
Why?
|
| Mannose-6-Phosphate Isomerase | 3 | 2004 | 3 | 0.730 |
Why?
|
| Ribosomal Proteins | 8 | 1998 | 18 | 0.730 |
Why?
|
| Catalytic Domain | 9 | 2019 | 99 | 0.720 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2012 | 103 | 0.700 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2018 | 85 | 0.700 |
Why?
|
| Protein Structure, Tertiary | 12 | 2010 | 322 | 0.690 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 166 | 0.660 |
Why?
|
| Protein Structure, Secondary | 10 | 2020 | 136 | 0.660 |
Why?
|
| Anti-Bacterial Agents | 5 | 2022 | 1026 | 0.630 |
Why?
|
| Acylation | 6 | 2019 | 22 | 0.600 |
Why?
|
| Peptidyl Transferases | 2 | 2010 | 5 | 0.550 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 24 | 0.540 |
Why?
|
| Carrier Proteins | 2 | 2014 | 597 | 0.540 |
Why?
|
| Pyruvate Kinase | 2 | 2013 | 5 | 0.530 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 133 | 0.530 |
Why?
|
| beta-Lactams | 2 | 2016 | 29 | 0.510 |
Why?
|
| DNA-Binding Proteins | 5 | 2018 | 700 | 0.500 |
Why?
|
| Enzyme Inhibitors | 5 | 2018 | 659 | 0.490 |
Why?
|
| Allosteric Regulation | 2 | 2018 | 58 | 0.480 |
Why?
|
| Transfection | 2 | 2016 | 782 | 0.480 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2021 | 226 | 0.480 |
Why?
|
| Crystallization | 9 | 2021 | 57 | 0.460 |
Why?
|
| Geobacillus stearothermophilus | 8 | 2003 | 9 | 0.460 |
Why?
|
| Cephalosporins | 3 | 2021 | 59 | 0.460 |
Why?
|
| Pyrococcus furiosus | 2 | 2003 | 5 | 0.460 |
Why?
|
| Glyceric Acids | 1 | 2013 | 1 | 0.460 |
Why?
|
| Mutation | 6 | 2019 | 1213 | 0.450 |
Why?
|
| Ceftriaxone | 3 | 2020 | 32 | 0.450 |
Why?
|
| Boron Compounds | 1 | 2012 | 21 | 0.430 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 48 | 0.410 |
Why?
|
| Staphylococcal Protein A | 1 | 2012 | 15 | 0.410 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 53 | 0.410 |
Why?
|
| Kinetics | 5 | 2014 | 1047 | 0.390 |
Why?
|
| Protein Binding | 8 | 2012 | 1027 | 0.390 |
Why?
|
| Recombinant Proteins | 7 | 2014 | 742 | 0.380 |
Why?
|
| RNA-Binding Proteins | 6 | 1998 | 215 | 0.370 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2009 | 3 | 0.350 |
Why?
|
| DNA, Single-Stranded | 1 | 2009 | 41 | 0.350 |
Why?
|
| Telomere | 1 | 2009 | 59 | 0.330 |
Why?
|
| Mutation, Missense | 4 | 2020 | 112 | 0.330 |
Why?
|
| Substrate Specificity | 6 | 2016 | 234 | 0.320 |
Why?
|
| Cysteine | 2 | 2005 | 112 | 0.310 |
Why?
|
| DNA Helicases | 2 | 2006 | 64 | 0.310 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 2 | 2007 | 39 | 0.300 |
Why?
|
| Catalysis | 7 | 2007 | 123 | 0.300 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2008 | 98 | 0.300 |
Why?
|
| Complement C8 | 1 | 2007 | 4 | 0.300 |
Why?
|
| Complement C9 | 1 | 2007 | 5 | 0.300 |
Why?
|
| DNA Replication | 2 | 2006 | 167 | 0.290 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2007 | 20 | 0.290 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 137 | 0.290 |
Why?
|
| CD59 Antigens | 1 | 2007 | 30 | 0.290 |
Why?
|
| Neisseria meningitidis | 1 | 2006 | 10 | 0.280 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2006 | 21 | 0.280 |
Why?
|
| Glycosyltransferases | 1 | 2006 | 13 | 0.270 |
Why?
|
| Plasmids | 1 | 2006 | 258 | 0.260 |
Why?
|
| Antigens, CD | 1 | 2006 | 230 | 0.260 |
Why?
|
| Hydrogen Bonding | 4 | 2017 | 67 | 0.260 |
Why?
|
| Structure-Activity Relationship | 5 | 2006 | 420 | 0.260 |
Why?
|
| Trans-Activators | 1 | 2006 | 237 | 0.250 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 199 | 0.250 |
Why?
|
| Ligands | 5 | 2004 | 317 | 0.250 |
Why?
|
| Boronic Acids | 1 | 2005 | 40 | 0.250 |
Why?
|
| Serine | 1 | 2005 | 99 | 0.250 |
Why?
|
| Escherichia coli Proteins | 1 | 2005 | 65 | 0.250 |
Why?
|
| Archaeal Proteins | 1 | 2004 | 5 | 0.250 |
Why?
|
| Oligopeptides | 1 | 2005 | 152 | 0.240 |
Why?
|
| Hydrolases | 1 | 2004 | 20 | 0.230 |
Why?
|
| Animals | 13 | 2021 | 20881 | 0.210 |
Why?
|
| Ribosomes | 2 | 2000 | 23 | 0.210 |
Why?
|
| Membrane Proteins | 2 | 2017 | 617 | 0.210 |
Why?
|
| Protein Domains | 2 | 2021 | 74 | 0.210 |
Why?
|
| Acne Vulgaris | 1 | 2022 | 11 | 0.200 |
Why?
|
| Tetracycline | 1 | 2022 | 29 | 0.200 |
Why?
|
| X-Ray Diffraction | 3 | 2010 | 53 | 0.200 |
Why?
|
| Acetylation | 2 | 2020 | 94 | 0.200 |
Why?
|
| Imipenem | 2 | 2012 | 9 | 0.200 |
Why?
|
| Borrelia burgdorferi | 1 | 2021 | 11 | 0.190 |
Why?
|
| Anemia, Hemolytic | 1 | 2001 | 37 | 0.190 |
Why?
|
| Cyclic GMP | 1 | 2021 | 99 | 0.190 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 2001 | 1 | 0.190 |
Why?
|
| Hexosyltransferases | 1 | 2001 | 1 | 0.190 |
Why?
|
| Alleles | 2 | 2019 | 386 | 0.190 |
Why?
|
| Species Specificity | 2 | 2016 | 303 | 0.190 |
Why?
|
| Static Electricity | 2 | 2014 | 91 | 0.190 |
Why?
|
| 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | 1 | 2000 | 1 | 0.180 |
Why?
|
| Peptidoglycan | 2 | 2016 | 14 | 0.180 |
Why?
|
| Cefixime | 1 | 2019 | 2 | 0.170 |
Why?
|
| Mice | 4 | 2021 | 8474 | 0.170 |
Why?
|
| Sulfates | 2 | 2013 | 28 | 0.160 |
Why?
|
| Nitrogen Isotopes | 1 | 2018 | 13 | 0.160 |
Why?
|
| Carbon Isotopes | 1 | 2018 | 54 | 0.160 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2018 | 21 | 0.160 |
Why?
|
| Protons | 1 | 2018 | 57 | 0.160 |
Why?
|
| Drug Resistance, Microbial | 1 | 1998 | 70 | 0.160 |
Why?
|
| Hydrolysis | 2 | 2010 | 144 | 0.150 |
Why?
|
| Rabbits | 3 | 2004 | 509 | 0.150 |
Why?
|
| Amino Acid Motifs | 2 | 2010 | 77 | 0.150 |
Why?
|
| Acinetobacter baumannii | 1 | 2018 | 22 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2006 | 231 | 0.150 |
Why?
|
| Transcription Factor CHOP | 1 | 2017 | 28 | 0.150 |
Why?
|
| Biofilms | 1 | 2018 | 72 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 70 | 0.140 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 49 | 0.140 |
Why?
|
| Alanine | 1 | 2017 | 38 | 0.140 |
Why?
|
| Goats | 2 | 2013 | 17 | 0.140 |
Why?
|
| Molecular Structure | 4 | 2010 | 397 | 0.140 |
Why?
|
| Cytokines | 1 | 2001 | 866 | 0.140 |
Why?
|
| RNA, Ribosomal | 1 | 1996 | 11 | 0.140 |
Why?
|
| Sequence Alignment | 4 | 2007 | 165 | 0.140 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2016 | 1 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 216 | 0.140 |
Why?
|
| Humans | 15 | 2022 | 68618 | 0.130 |
Why?
|
| Cell Line | 2 | 2017 | 1752 | 0.130 |
Why?
|
| Cattle | 1 | 2016 | 475 | 0.130 |
Why?
|
| Penicillin Resistance | 1 | 2014 | 12 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 1 | 2014 | 24 | 0.120 |
Why?
|
| Glucose-6-Phosphate | 2 | 2004 | 2 | 0.120 |
Why?
|
| In Vitro Techniques | 2 | 2007 | 765 | 0.120 |
Why?
|
| Apoenzymes | 2 | 2012 | 2 | 0.120 |
Why?
|
| Aspartic Acid | 1 | 2014 | 65 | 0.120 |
Why?
|
| Pentosephosphates | 2 | 2004 | 3 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2004 | 204 | 0.120 |
Why?
|
| Goat Diseases | 1 | 2013 | 1 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1293 | 0.110 |
Why?
|
| Vena Cava, Superior | 1 | 2013 | 41 | 0.110 |
Why?
|
| Allosteric Site | 1 | 2013 | 17 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 511 | 0.110 |
Why?
|
| Glycolysis | 1 | 2013 | 79 | 0.110 |
Why?
|
| Potassium | 1 | 2013 | 168 | 0.110 |
Why?
|
| Fluorescence Polarization | 1 | 2012 | 14 | 0.110 |
Why?
|
| beta-Lactam Resistance | 1 | 2012 | 6 | 0.110 |
Why?
|
| Pacemaker, Artificial | 1 | 2013 | 157 | 0.110 |
Why?
|
| Bison | 1 | 2012 | 1 | 0.100 |
Why?
|
| Gammaherpesvirinae | 1 | 2012 | 2 | 0.100 |
Why?
|
| Temperature | 2 | 2017 | 341 | 0.100 |
Why?
|
| Dogs | 1 | 2013 | 490 | 0.100 |
Why?
|
| Penicillin G | 1 | 2012 | 8 | 0.100 |
Why?
|
| Herpesviridae Infections | 1 | 2012 | 23 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2014 | 483 | 0.100 |
Why?
|
| Molecular Docking Simulation | 1 | 2012 | 78 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2018 | 1200 | 0.100 |
Why?
|
| Swine | 1 | 2013 | 672 | 0.100 |
Why?
|
| Protein Folding | 4 | 2006 | 82 | 0.090 |
Why?
|
| Cloxacillin | 1 | 2010 | 2 | 0.090 |
Why?
|
| Cefoxitin | 1 | 2010 | 20 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 277 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 249 | 0.090 |
Why?
|
| Succinimides | 1 | 2010 | 11 | 0.090 |
Why?
|
| Disulfides | 1 | 2010 | 40 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 60 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2010 | 358 | 0.090 |
Why?
|
| Transglutaminases | 1 | 2010 | 67 | 0.090 |
Why?
|
| Acetates | 1 | 2010 | 74 | 0.080 |
Why?
|
| Deoxycytidine | 1 | 2009 | 83 | 0.080 |
Why?
|
| Protein Denaturation | 1 | 2008 | 27 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1745 | 0.080 |
Why?
|
| United States | 1 | 2021 | 7367 | 0.080 |
Why?
|
| Aspirin | 1 | 2010 | 295 | 0.080 |
Why?
|
| Doxorubicin | 1 | 2009 | 231 | 0.080 |
Why?
|
| Crystallography | 2 | 2004 | 8 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2018 | 57 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2006 | 324 | 0.070 |
Why?
|
| Muscles | 1 | 1987 | 158 | 0.070 |
Why?
|
| Base Sequence | 2 | 2018 | 1015 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 56 | 0.070 |
Why?
|
| Meningococcal Infections | 1 | 2006 | 5 | 0.070 |
Why?
|
| Arginine | 1 | 2007 | 102 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 1998 | 181 | 0.070 |
Why?
|
| Carbohydrates | 1 | 2006 | 57 | 0.070 |
Why?
|
| DNA | 2 | 2006 | 597 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2018 | 791 | 0.060 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2005 | 4 | 0.060 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2005 | 24 | 0.060 |
Why?
|
| Organophosphonates | 1 | 2005 | 16 | 0.060 |
Why?
|
| Streptomyces | 1 | 2005 | 15 | 0.060 |
Why?
|
| Streptococcus pneumoniae | 1 | 2005 | 32 | 0.060 |
Why?
|
| Mannosephosphates | 1 | 2004 | 1 | 0.060 |
Why?
|
| Structural Homology, Protein | 1 | 2004 | 16 | 0.060 |
Why?
|
| Fructosephosphates | 1 | 2004 | 1 | 0.060 |
Why?
|
| Sugar Phosphates | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 1851 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 122 | 0.060 |
Why?
|
| Multigene Family | 1 | 2004 | 93 | 0.060 |
Why?
|
| Gluconates | 1 | 2003 | 5 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2012 | 150 | 0.060 |
Why?
|
| Carbon Dioxide | 1 | 2004 | 78 | 0.060 |
Why?
|
| Hydrogen | 1 | 2003 | 35 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1070 | 0.050 |
Why?
|
| Minocycline | 1 | 2022 | 61 | 0.050 |
Why?
|
| Isomerism | 1 | 2001 | 63 | 0.050 |
Why?
|
| Phosphates | 1 | 2001 | 72 | 0.050 |
Why?
|
| beta-Lactamases | 1 | 2001 | 33 | 0.050 |
Why?
|
| Electrons | 1 | 2000 | 25 | 0.040 |
Why?
|
| Movement | 1 | 2001 | 179 | 0.040 |
Why?
|
| X-Rays | 1 | 2000 | 56 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 302 | 0.040 |
Why?
|
| Rats | 2 | 2007 | 5300 | 0.040 |
Why?
|
| HLA-DR1 Antigen | 1 | 1998 | 2 | 0.040 |
Why?
|
| Anemia, Hemolytic, Congenital Nonspherocytic | 1 | 1998 | 1 | 0.040 |
Why?
|
| CD4 Antigens | 1 | 1998 | 42 | 0.040 |
Why?
|
| Female | 1 | 2021 | 38074 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2018 | 74 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2001 | 332 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2018 | 50 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 357 | 0.040 |
Why?
|
| Bacteriophage T4 | 1 | 1997 | 5 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 1998 | 142 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 90 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 1996 | 83 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 235 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 2016 | 27 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1997 | 226 | 0.030 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 1996 | 3 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1996 | 150 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 615 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1996 | 79 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1995 | 86 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1692 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1997 | 753 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2013 | 218 | 0.030 |
Why?
|
| Sheep | 1 | 2012 | 128 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2012 | 114 | 0.020 |
Why?
|
| Immunity | 1 | 2012 | 67 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1998 | 346 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 127 | 0.020 |
Why?
|
| Virus Replication | 1 | 2012 | 104 | 0.020 |
Why?
|
| Heart Rate | 1 | 2013 | 568 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 2791 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2013 | 586 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 318 | 0.020 |
Why?
|
| Adolescent | 1 | 2022 | 8912 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 231 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1330 | 0.020 |
Why?
|
| Phosphoenolpyruvate | 1 | 1987 | 1 | 0.020 |
Why?
|
| Cations | 1 | 1987 | 51 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cats | 1 | 1987 | 292 | 0.020 |
Why?
|
| Lung | 1 | 2012 | 849 | 0.020 |
Why?
|
| NADP | 1 | 2007 | 39 | 0.020 |
Why?
|
| Dimerization | 2 | 1997 | 99 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1987 | 308 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1987 | 314 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2550 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1998 | 165 | 0.010 |
Why?
|
| CHO Cells | 1 | 1998 | 161 | 0.010 |
Why?
|
| Cricetinae | 1 | 1998 | 262 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 1998 | 76 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 67 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1998 | 294 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1998 | 85 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 208 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1998 | 228 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 532 | 0.010 |
Why?
|
| DnaB Helicases | 1 | 1996 | 14 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 1996 | 30 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 272 | 0.010 |
Why?
|
| Peptides | 1 | 1998 | 455 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1998 | 597 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1998 | 1664 | 0.010 |
Why?
|